Jakob Dupont - Sep 22, 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Jakob Dupont
Stock symbol
PYXS
Transactions as of
Sep 22, 2023
Transactions value $
$0
Form type
4
Date filed
9/26/2023, 07:04 PM
Previous filing
Aug 25, 2023
Next filing
Mar 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +392K $0.00 392K Sep 22, 2023 Common Stock 392K $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in three equal annual installments beginning on the first anniversary of August 23, 2023, subject to the reporting person's continued service through the applicable vesting date.